Results 131 to 140 of about 1,041,491 (350)
We propose a method for finding metabolic parameters of cells, organs and whole organisms, which is based on the earlier discovered general growth law.
Shestopaloff, Yuri K.
core +2 more sources
Hypoxanthine, a Growth Substance for Phycomyces [PDF]
W J, Robbins, F, Kavanagh
openaire +2 more sources
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Changes in physical and chemical variables [PDF]
An article reviewing the work undertaken looking at the seasonal variation of chemical conditions in water at various depths in lakes. The laboratory tests undertaken for the research is outlined, as well as details of the sampling locations and the ...
Mortimer, C.H.
core
(Uploaded by Plazi from the Biodiversity Heritage Library) No abstract provided.
openaire +2 more sources
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
The influence of blue-green algae on development of the zooplankton. [Translation of: Byull.mosk.Obshch.Ispyt.Prir.(Biol.) 67, 128-131, 1962] [PDF]
Many have observed the reduction of the quantity of zooplankton in the presence of water blooms. It is known that in seas zooplankton as it were avoids places of accumulation of blue-green algae.
Manuilova, E. F.
core
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source

